Literature DB >> 6281785

[half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.

T K Sawyer, V J Hruby, P S Darman, M E Hadley.   

Abstract

alpha-Melanocyte-stimulating hormone (alpha-melanotropin; alpha-MSH) is a linear tridecapeptide (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) that reversibly darkens amphibian skins by stimulating melanomsome (pigment granule) dispersion within melanophores. By using a number of in vitro melanocyte assays, we have examined the conformational requirements for alpha-MSH activity. Synthesis of [half-Cys4,half-Cys10]-alpha-MSH, a cyclic, conformationally restricted, "isosteric" analogue of alpha-MSH, provided a melanotropin with a potency greater than 10,000 times that of the native hormone in stimulating frog (Rana pipiens) skin darkening. The cyclic analogue also showed substantially prolonged activity relative to the native hormone. [half-Cys4,half-Cys10]-alpha-MSH was approximately 30 times more potent than alpha-MSH in stimulating lizard (Anolis carolinensis) skin melanophores in vitro. By using a cell-free Cloudman S-91 mouse melanoma plasma membrane preparation, we found the cyclic analogue to be approximately 3 times as potent as the native hormone in stimulating adenylate cyclase activity. These results provide insight into the conformational requirements for biological activity of alpha-MSH, and the comparative conformational requirements of alpha-MSH at a number of pigment cell receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281785      PMCID: PMC346058          DOI: 10.1073/pnas.79.6.1751

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  ACTH: a short introductory review.

Authors:  R Schwyzer
Journal:  Ann N Y Acad Sci       Date:  1977-10-28       Impact factor: 5.691

2.  Indentification of sites in oxytocin involved in uterine receptor recognition and activation.

Authors:  P Walter
Journal:  Fed Proc       Date:  1977-05

3.  Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism.

Authors:  J P Meraldi; V J Hruby; A I Brewster
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

Review 4.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

5.  Highly active cyclic and bicyclic somatostatin analogues of reduced ring size.

Authors:  D F Veber; F W Holly; R F Nutt; S J Bergstrand; S F Brady; R Hirschmann; M S Glitzer; R Saperstein
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

6.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

7.  Conformation of the LL and LD hairpin bends with internal hydrogen bonds in proteins and peptides.

Authors:  R Chandrasekaran; A V Lakshminarayanan; U V Pandya; G N Ramachandran
Journal:  Biochim Biophys Acta       Date:  1973-03-23

8.  Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units.

Authors:  C M Venkatachalam
Journal:  Biopolymers       Date:  1968-10       Impact factor: 2.505

9.  Adenosine and divalent cation effects on S-91 melanoma adenylate cyclase.

Authors:  M D Bregman; T K Sawyer; M E Hadley; V J Hruby
Journal:  Arch Biochem Biophys       Date:  1980-04-15       Impact factor: 4.013

10.  Synthesis of alpha- and beta-melanocyte stimulating hormones.

Authors:  Y C Yang; V J Hruby; C B Heward; M E Hadley
Journal:  Int J Pept Protein Res       Date:  1980-02
View more
  27 in total

1.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

2.  Interaction of alpha-melanocyte stimulating hormone with binary phospholipid membranes: structural changes and relevance of phase behavior.

Authors:  L M Contreras; R F de Almeida; J Villalaín; A Fedorov; M Prieto
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

Review 3.  Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations.

Authors:  V J Hruby; F al-Obeidi; W Kazmierski
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

Review 4.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

5.  Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).

Authors:  Anamika Singh; Marvin Dirain; Rachel Witek; James R Rocca; Arthur S Edison; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

Review 6.  Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

Authors:  Victor J Hruby; Minying Cai; James Cain; Joel Nyberg; Dev Trivedi
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

Review 7.  Design of cyclic peptides with biological activities from biologically active peptides: the case of peptide modulators of melanocortin receptors.

Authors:  Victor J Hruby
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

Review 8.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

Review 9.  Design of cyclized selective melanotropins.

Authors:  Minying Cai; Victor J Hruby
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

10.  Beta-turn secondary structure and melanocortin ligands.

Authors:  Erica M Haslach; Jay W Schaub; Carrie Haskell-Luevano
Journal:  Bioorg Med Chem       Date:  2008-03-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.